Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: A 24-week follow-up study
International Clinical Psychopharmacology Jan 31, 2018
Chan CH, et al. - Psychotic patients with a pre-existing tardive dyskinesia (TD) were examined for the effectiveness of aripiprazole. Findings revealed that for clinicians considering drug switch in psychotic patients with TD, aripiprazole can be a promising treatment
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries